TY - JOUR
KW - Analgesics, Opioid/adverse effects
KW - Attitude of Health Personnel
KW - Codeine/adverse effects
KW - Drug and Narcotic Control
KW - Health Policy
KW - Humans
KW - Nonprescription Drugs/adverse effects
KW - Opioid-Related Disorders/diagnosis/epidemiology/therapy
KW - Physician's Role
KW - Practice Guidelines as Topic
KW - Practice Patterns, Physicians'/legislation & jurisprudence/standards
KW - Risk Assessment
KW - Risk Factors
KW - Substance Abuse Detection
AU - M. Bergin
AU - I. Norman
AU - M. Foley
AU - R. Harris
AU - A. Rapca
AU - E. Rich
AU - M. C. Van Hout
A1 - 
AB - Codeine, a weak opiate, requires increased pharmacovigilance relating to availability, heterogeneous nature of misuse, dependence and associated harm. A scoping review of literature on codeine was conducted using Arksey & O'Malley's framework (1). Databases searched included PubMed, EBSCO Host, Science Direct, EMBASE, PsycINFO, Cochrane library and Medline from 1994 to 2014. Follow-up search strategies involved hand searching and searching of pharmaceutical, health, medical and drug related websites. Initial zscreening identified 3,105 articles with 475 meeting the inclusion criteria. Eight broad categories organised the literature, data charting and qualitative synthesis. This paper presents implications for practice and makes recommendations to address these issues. Themes identified relate to raising public and practitioner awareness, risk management, dispensing practices and monitoring and surveillance of codeine. Evidence to inform law enforcement, drug surveillance, public health initiatives, harm reduction approaches, pharmacy, clinical and treatment practices is warranted.
BT - Acta pharmaceutica (Zagreb, Croatia)
C5 - Opioids & Substance Use; Education & Workforce
CP - 4
CY - Croatia
DO - 10.1515/acph-2015-0040
IS - 4
JF - Acta pharmaceutica (Zagreb, Croatia)
N2 - Codeine, a weak opiate, requires increased pharmacovigilance relating to availability, heterogeneous nature of misuse, dependence and associated harm. A scoping review of literature on codeine was conducted using Arksey & O'Malley's framework (1). Databases searched included PubMed, EBSCO Host, Science Direct, EMBASE, PsycINFO, Cochrane library and Medline from 1994 to 2014. Follow-up search strategies involved hand searching and searching of pharmaceutical, health, medical and drug related websites. Initial zscreening identified 3,105 articles with 475 meeting the inclusion criteria. Eight broad categories organised the literature, data charting and qualitative synthesis. This paper presents implications for practice and makes recommendations to address these issues. Themes identified relate to raising public and practitioner awareness, risk management, dispensing practices and monitoring and surveillance of codeine. Evidence to inform law enforcement, drug surveillance, public health initiatives, harm reduction approaches, pharmacy, clinical and treatment practices is warranted.
PP - Croatia
PY - 2015
SN - 1846-9558; 1330-0075
SP - 351
EP - 364
EP - 
T1 - Practice implications and recommendations for managing codeine misuse and dependence
T2 - Acta pharmaceutica (Zagreb, Croatia)
TI - Practice implications and recommendations for managing codeine misuse and dependence
U1 - Opioids & Substance Use; Education & Workforce
U2 - 26677894
U3 - 10.1515/acph-2015-0040
VL - 65
VO - 1846-9558; 1330-0075
Y1 - 2015
ER -